Vivek Garipalli
CIK 1839260 · Executive Chairperson · last filed 2026-01-09
Vivek Garipalli is an Executive Chairperson who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for CLOV, was dated Jan 9, 2026. Across all open-market trades the lifetime net is +$3.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $16.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.61M
2
9
$3.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLOV | Director | 3,512,196 | $4.73 | $16.61M | $3.00M | 8 | 2026-01-09 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Chief Executive Officer | — | $2.02 | — | $0 | 1 | 2021-01-11 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-09 | CLOV | Mixed | — | -$4.29M | EDGAR |
| 2025-08-08 | CLOV | Buy (P) | +446,980 | $999.0K | EDGAR |
| 2025-01-10 | CLOV | Mixed | — | -$6.02M | EDGAR |
| 2024-08-13 | CLOV | Buy (P) | +531,700 | $999.6K | EDGAR |
| 2024-06-20 | CLOV | Buy (P) | +877,567 | $1.00M | EDGAR |
| 2024-01-09 | CLOV | Mixed | — | -$1.48M | EDGAR |
| 2023-04-28 | CLOV | Mixed | — | -$1.59M | EDGAR |
| 2022-01-11 | CLOV | Mixed | +1,677,873 | -$5.26M | EDGAR |
| 2021-01-11 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Grant (A) | — | $0 | EDGAR |